Thus, we investigated the galectin-1 expression by immunohistochemistry (IHC) and demonstrated its role in 93 patients with locally advanced ESCC treated with preoperative CCRT. The gene discussed is LGALS1; the disease is esophageal squamous cell carcinoma.